Compound Detail
CHEMBL4571897
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CCC(CC)n1cnc2c(NCc3c(C)cc(C)[nH]c3=O)nc(-c3ccc(OC(F)(F)F)cc3)nc21
Basic Information
| ChEMBL ID | CHEMBL4571897 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | HEKUCBVDWDVKBL-UHFFFAOYSA-N |
3
Targets
3
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
500.5
MW (Da)
5.67
ALogP
7
HBA
2
HBD
97.7
PSA (Ų)
0.32
QED
2
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 6.11
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| HCT-116 | IC50 | = | 780.0 | nM | 6.11 | Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay | 31610375 |
| HepG2 | IC50 | = | 1420.0 | nM | 5.85 | Antiproliferative activity against human HepG2 cells after 72 hrs by MTT assay | 31610375 |
| A549 | IC50 | = | 5380.0 | nM | 5.27 | Antiproliferative activity against human A549 cells after 72 hrs by MTT assay | 31610375 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 31610375 | 10.1016/j.ejmech.2019.111728 | HepG2 | 1 |
| 31610375 | 10.1016/j.ejmech.2019.111728 | A549 | 1 |
| 31610375 | 10.1016/j.ejmech.2019.111728 | HCT-116 | 1 |
Data from ChEMBL 36 via Core Engine